AI drug discovery platform gets £1m innovation boost
Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward today (September 19) as Optibrium, Intellegens, and Medicines Discovery Catapult secure a grant from Innovate UK to fund a £1m project.
The programme will see Optibrium, which creates software to improve the efficiency and productivity of drug discovery, and Intellegens, a spin out from the University of Cambridge which is focused on a specific form of AI called ‘deep learning’, work with Medicines Discovery Catapult, based on Al... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
